Finance

Beta
Lists
603079:SHA
Zhejiang Shengda Bio-pharm Co Ltd
CN¥13.03
+1.24%
(+0.16) 1D
Jun 9, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603079...
Open
CN¥12.99
High
CN¥13.25
Low
CN¥12.75
Mkt. cap
2.43B
Avg. vol.
3.35M
Volume
1.91M
P/E ratio
44.17
52-wk high
CN¥22.00
52-wk low
CN¥12.71
EPS
CN¥0.30
Shares outstanding
112.00M
No. of employees
1K
Open
CN¥12.99
High
CN¥13.25
Low
CN¥12.75
Mkt. cap
2.43B
Avg. vol.
3.35M
Volume
1.91M
P/E ratio
44.17
52-wk high
CN¥22.00
52-wk low
CN¥12.71
EPS
CN¥0.30
Shares outstanding
112.00M
No. of employees
1K
News stories
From sources across the web
About Zhejiang Shengda Bio-pharm Co Ltd
CEO-
Employees1.08K
FoundedFeb 8, 1999
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Dec 2024
Mar 2025
Dec 2025
Mar 2026
Revenue
218.53M
203.23M
223.25M
189.22M
Cost of goods sold
177.89M
144.50M
175.36M
136.99M
Cost of revenue
177.89M
144.50M
175.36M
136.99M
Research and development expenses
14.74M
10.16M
18.11M
10.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.02M
17.53M
22.59M
20.29M
Operating expense
35.54M
28.59M
48.77M
31.77M
Total operating expenses
213.42M
173.09M
224.13M
168.75M
Operating income
5.11M
30.14M
-879.22K
20.46M
Other non operating income
-8.93M
86.11K
283.41K
-3.83M
EBT including unusual items
13.88M
27.74M
8.03M
18.58M
EBT excluding unusual items
842.01K
31.07M
-279.90K
19.37M
Income tax expense
4.03M
4.32M
-2.51M
3.27M
Effective tax rate
29.04%
15.57%
-31.26%
17.59%
Other operating expenses
4.98M
264.36K
7.99M
1.54M
Net income
7.75M
21.71M
8.82M
13.17M
Net profit margin
3.54%
10.68%
3.95%
6.96%
Earnings per share
-
-
-
-
Interest and investment income
1.55M
1.09M
2.80M
2.86M
Interest expense
-976.21K
-250.83K
-45.11K
-115.42K
Net interest expenses
573.70K
843.82K
2.75M
2.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
23.63M
48.66M
17.98M
39.32M
Gain or loss from assets sale
-145.97K
-
477.31K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more